Third-Quarter Semiconductor Market Performance Drives MKS Instruments Past Projections - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Third-Quarter Semiconductor Market Performance Drives MKS Instruments Past Projections

    Article obtained from Photonics RSS Feed.

    MKS Instruments reported quarterly consolidated revenue of $589.8 million, up 28% year over year and nearly $46 million from last quarter. The company reported non-GAAP net earnings per share (EPS) of $1.93 — a 72% increase from last year’s third quarter and 31 cents from last quarter.

    For the quarter, MKS reported a profit of just under $92 million, and $107 million (non-GAAP).

    The company’s reported GAAP EPS was $1.66, which represents a 33 cent increase from the previous quarter.

    “We delivered record quarterly revenue for MKS, led by record Semiconductor Market revenue and a recovery in our Advanced Markets revenue,” said John TC Lee, MKS Instruments’ president and CEO. “Demand…

    READ MORE
    Oct, 27 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.